Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Working Capital Changes (2020 - 2025)

LifeStance Health (LFST) has disclosed Other Working Capital Changes for 6 consecutive years, with $36.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 391.41% to $36.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.7 million, a 199.87% increase, with the full-year FY2025 number at $46.7 million, up 199.87% from a year prior.
  • Other Working Capital Changes was $36.3 million for Q4 2025 at LifeStance Health, up from $33.9 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $69.2 million in Q3 2023 to a low of -$89.9 million in Q4 2023.
  • A 5-year average of -$3.5 million and a median of -$8.2 million in 2023 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: crashed 2718.97% in 2023, then surged 391.41% in 2025.
  • LifeStance Health's Other Working Capital Changes stood at -$32.9 million in 2021, then surged by 110.43% to $3.4 million in 2022, then plummeted by 2718.97% to -$89.9 million in 2023, then skyrocketed by 86.15% to -$12.4 million in 2024, then soared by 391.41% to $36.3 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Other Working Capital Changes are $36.3 million (Q4 2025), $33.9 million (Q3 2025), and -$28.0 million (Q2 2025).